| 000 | 05754nam a22004455i 4500 | ||
|---|---|---|---|
| 999 |
_c9806 _d9806 |
||
| 001 | 9806 | ||
| 003 | ES-VaUE | ||
| 005 | 20210519100805.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 201105s2021 gw | o |||| 0|eng d | ||
| 020 | _a3030491404 | ||
| 024 | 7 |
_a10.1007/978-3-030-49140-6 _2doi |
|
| 040 |
_bspa _dES-VaUE |
||
| 050 | _b.B43 2021 EB | ||
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 072 | 7 |
_aMJCL _2thema |
|
| 082 | 0 | 4 |
_a616.994 _223 |
| 245 | 1 | 0 |
_aLate Treatment Effects and Cancer Survivor Care in the Young _bFrom Childhood to Early Adulthood _cedited by Jörn D. Beck, Carsten Bokemeyer, Thorsten Langer |
| 250 | _a1st ed. 2021 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _bImprint: Springer _c2021 |
|
| 300 | _a1 online resource (VIII, 439 p. 46 illus., 33 illus. in color.) | ||
| 336 |
_atext _btxt [ _2rdacontent] |
||
| 337 |
_acomputer _bc [ _2rdamedia] |
||
| 338 |
_aonline resource _bcr [ _2rdacarrier] |
||
| 505 | 0 | _aChapter 1. Cardiotoxicity after Childhood Cancer Treatment -- Chapter 2. Kidney -- Chapter 3. Ototoxicity after Childhood Cancer Treatment -- Chapter 4. Complications in tumour orthopaedics -- Chapter 5. Causes and course of (severe) late effects – GI tract -- Chapter 6. Pulmonary toxicity - Causes and course of (severe) late effects in the Lungs -- Chapter 7. Growth hormone deficiency in adult childhood cancer survivors -- Chapter 8. Endocrine Late Effects – Thyroid Gland -- Chapter 9. Disorders of gonadal and reproductive function in survivors of childhood cancer -- Chapter 10. Fertility protection in childhood, adolescents and young adulthood cancer patients -- Chapter 11. Endocrine Late Effects - Adrenal Gland -- Chapter 12. Pregnancy and Birth -- Chapter 13. Endocrine Late Effects - Obesity and Metabolic Syndrome after Childhood Cancer -- Chapter 14. Subsequent primary cancer after childhood, teenage and young adult cancer -- Chapter 15. Diagnostic of Late Treatment effects: Neuropsychological Short Assessment of Disease- and Treatment-related Intelligence Deficits in Children with Brain Tumors -- Chapter 16. Long-term Positive and Negative Psychosocial Outcomes in Young Childhood Cancer Survivors and their Healthy Peers – Posttraumatic Stress Disorder / Somatoform Disorder -- Chapter 17. Cancer related fatigue -- Chapter 18. Late effects after treatment of acute lymphoblastic leukemia in childhood and adolescence -- Chapter 19. Late effects after treatment of acute myeloic leukemia -- Chapter 20. Side Effects and Sequelae of Treatment for Chronic Myeloid Leukemia in Childhood and Adolescence -- Chapter 21. Late effects after treatment of Non-Hodgkin lymphoma in childhood and adolescents -- Chapter 22. Late effects after treatment of Hodgkin lymphoma -- Chapter 23. Langerhans Cell Histiocytosis -- Chapter 24. Diagnostics and Diagnosis of Late Effects in Childhood Brain Tumour Survivors -- Chapter 25. Late effects in children and adolescents with neuroblastoma -- Chapter 26. Late effects in children and adolescents with nephroblastoma -- Chapter 27. Hepatoblastoma and Hepatocellular Carcinoma -- Chapter 28. Long Term Sequelae after retinoblastoma -- Chapter 29. Late effects in children and adolescents with Ewing Sarcoma -- Chapter 30. Late effects in children and adolescents with osteosarcoma -- Chapter 31. Late effects in children and adolescents with soft tissue sarcoma -- Chapter 32. Potential late effects of rhabdoid tumor therapy -- Chapter 33. Late effects after treatment of malignant endocrine tumors -- Chapter 34. Skin cancer – treatment and implications for the long term follow up -- Chapter 35. Breast Cancer -- Chapter 36. Colorectal carcinoma -- Chapter 37. Genetic predisposition to late effects - pharmacogenomics of cisplatin-induced ototoxicity -- Chapter 38. Physical activity, exercise, and sports -- Chapter 39. Late effects after radiotherapy -- Chapter 40. Long-Term Follow-Up from the Point of View of a Person Affected -- Chapter 41. Networks of Survivorship Care | |
| 520 | _aThis comprehensive guide describes the aftercare that is appropriate in young cancer patients and discusses in detail the risk and detection of treatment sequelae. It explains the impacts on body and mind of both the disease itself and the different risk-adapted cancer treatments currently in use. Clear guidance is provided on diagnosis and management of the principal treatment-related toxicities in different organs and organ systems and for a wide variety of tumor types. In addition, the role of genetic polymorphisms in the development of adverse therapy-related outcomes is explored, and advice offered on genetic counselling. As the number of long-term survivors of childhood cancer and of cancer in young adults continues to grow, so issues surrounding potential sequelae, second malignancies, and quality of life are becoming ever more important. All practitioners involved in the care of young cancer patients will find this book to be a helpful source of up-to-date information and assistance | ||
| 650 | 0 | _aOncology | |
| 650 | 0 | _aPediatrics | |
| 650 | 1 | 4 | _aOncology. |
| 650 | 2 | 4 | _aPediatrics. |
| 700 | 1 |
_aBeck, Jörn D., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aBokemeyer, Carsten., _eeditor _4edt. _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aLanger, Thorsten., _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 776 | _z3-030-49138-2 | ||
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-49140-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 | _db | ||